REVIEW ARTICLE Pamela N. Munster; ONCOLOGY Vol. 27 No. 6
In the short period of time in which newly diagnosed women will need to make decisions about surgical options and adjuvant therapy, younger women with breast cancer also face the potential impairment or complete loss of their fertility.
HOW AN EXPERT APPROACHES IT Roisin M. Connolly, Vered Stearns; ONCOLOGY Vol. 27 No. 6
The goals of care for patients with hormone receptor (HR)-positive advanced breast cancer include prolongation of disease-free and overall survival, amelioration of symptoms, and improvement in quality of life.
CLINICAL QUANDARIES Anthony D. Elias, Sharon Sams; ONCOLOGY Vol. 27 No. 6
The Case: A 48-year-old perimenopausal woman noted a lump in her left breast. She had had a mammogram 9 months earlier without abnormality. After ultrasound imaging confirmed a solitary mass measuring about 1.5 cm, a core needle biopsy demonstrated a poorly differentiated mammary carcinoma with chondroid features.
REVIEW ARTICLE Mark Messina et al; ONCOLOGY Vol. 27 No. 5
Recently published research questions the need for the advised restriction against the use of soyfoods by women with a history of breast cancer.
RESEARCH REPORT Anna Azvolinsky
The US Preventive Services Task Force, an influential panel of experts, said that women at high risk for breast cancer should consider taking breast cancer drugs to decrease their risk. The analysis of the research on which the recommendation is based is published in the Annals of Internal Medicine.
The goals of care for patients with hormone receptor (HR)-positive advanced breast cancer include prolongation of disease-free and overall survival, amelioration of symptoms, and improvement in quality of life.
A considerable number of women with breast cancer are diagnosed during their reproductive years. In the short period of time in which newly diagnosed women will need to make decisions about surgical options and adjuvant therapy, younger women with breast cancer also face the potential impairment or complete loss of their fertility.
The Case: A 48-year-old perimenopausal woman noted a lump in her left breast. She had had a mammogram 9 months earlier without abnormality. After ultrasound imaging confirmed a solitary mass measuring about 1.5 cm, a core needle biopsy demonstrated a poorly differentiated mammary carcinoma with chondroid features.
A 22-year-old female collegiate soccer player complains of a painful palpable area in her right breast accompanied by a straw-colored nipple discharge. Because she is extremely anxious and has had previous excisional biopsies, you decide to perform a lumpectomy.
A 38-year-old female (para 3, gravida 3), complains of persistent bilateral mammary gland pain associated with a “lumpy” feeling when she does a self-examination. She carries a family history of breast cancer in both her mother and older sister.
A 71-year-old woman was receiving a multi-agent chemotherapeutic regimen following a lumpectomy for breast cancer. After the second round of treatment, she presented for medical care due to persistent, intensely painful ulceration of the contralateral breast.
A 31-year-old woman has undergone a lumpectomy for a small, estrogen receptor–positive breast tumor. She acutely develops a painful, hot fluctuant lump on her chin. What would be the most appropriate thing to do first?
A single-center study analyzed the frequency of breast cancer susceptibility mutations among black women diagnosed with breast cancer. The findings... More »
A study presented at ASCO shows that axillary radiotherapy results in similar outcomes to axillary lymph node dissection, but halved the incidence of... More »
A phase III trial presented at ASCO showed similar efficacy between two adjuvant paclitaxel regimens, but the weekly regimen led to fewer patient side... More »
Women diagnosed with estrogen-receptor (ER)-positive breast cancer who took tamoxifen for 10 years as adjuvant therapy had lower risk of late... More »
Ahead of the ASCO 2013 meeting we discuss neoadjuvant therapy options and clinical trials in breast cancer, as well as the opportunities for targeted therapies in post-neoadjuvant trials.
This year's coverage of the European Society for Medical Oncology (ESMO) 2012 Congress includes write-ups of the most important information to come out of this year's event.
Key Differences between FQHCs and RHCs Chastity Werner, RHIT, June 13, 2013 FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice Susanne Madden, June 12, 2013 Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices Ericka L. Adler, June 12, 2013 Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
iPad Alternatives for Mobile Physicians Marisa Torrieri, June 11, 2013 As more physicians are seeing the merits of media tablets, the market is expanding, too.